Puriblood Medical Co., Ltd.

Taipei Exchange 6847.TWO

Puriblood Medical Co., Ltd. Free Cash Flow Yield on January 14, 2025: 1.53%

Puriblood Medical Co., Ltd. Free Cash Flow Yield is 1.53% on January 14, 2025, a 11.71% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Puriblood Medical Co., Ltd. 52-week high Free Cash Flow Yield is 1.81% on November 06, 2024, which is 18.81% above the current Free Cash Flow Yield.
  • Puriblood Medical Co., Ltd. 52-week low Free Cash Flow Yield is 1.37% on July 29, 2024, which is -10.48% below the current Free Cash Flow Yield.
  • Puriblood Medical Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 1.60%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Taipei Exchange: 6847.TWO

Puriblood Medical Co., Ltd.

CEO Dr. Luke Chen
IPO Date Nov. 5, 2021
Location
Headquarters No.11, Gongye East 9th Road
Employees 42
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Puriblood Medical Co., Ltd. develops and sells blood cell separation products in Taiwan. The company offers leukocyte reduction filters for red blood cells, platelets, and whole blood, as well as real-time filtration sets for whole blood. It also offers Devin blood fractionation membrane filters and Minipuri cell screening syringe filters. In addition, the company develops P-Tex Technology, which is composed by bio-inspired molecular formula – zwitterionic copolymer structure. Puriblood Medical Co., Ltd. was founded in 2016 and is based in Hsinchu City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email